A single class of drug has the potential to treat infectious…
Category: Oncology
Home /
Vitamin D is an essential nutrient, best known for helping the…
Pancreatic cancer is an aggressive, highly lethal malignancy, with some of…
Throughout the human body, in virtually every tissue and organ, white…
Today’s cancer drugs are more sophisticated and accessible than ever before….
At age 29, with unrelenting abdominal pain, Ryan Decembrino pushed past…
Picture your GPS system of choice — Google Maps, Apple Maps,…
Cancer’s cruelest trick might be its ability to migrate from its…
Hair thinning and loss are highly visible and common changes associated…
Six nurses working on the fifth-floor maternity unit at Newton-Wellesley Hospital…
New research continually adds to our knowledge of the effects of…
In mammography, “density” refers to the amount of dense tissue present…
Men with early-stage prostate cancer may have a new tool to…
Scientists have designed a new gene therapy strategy that uses an…
A new contender in the fight against lung cancer has emerged,…
Tecelra®, the first engineered T-cell therapy for solid tumors, has received…
Clinical trial results show that pembrolizumab, an immunotherapy drug used to…
In the early days of the human immunodeficiency virus (HIV) epidemic,…
In a pioneering first-in-human clinical trial, an mRNA cancer vaccine developed…
Around 200,000 people die from glioblastoma, the most common and most…
Executive Summary Biosimilars have advanced from a promising idea to a proven pathway for expanding patient access to biologic therapies and easing pressure on…
Introduction Real-world evidence (RWE) is accelerating drug development by using routinely collected patient health data, known as real-world data (RWD), to deliver insights beyond…
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
NEWARK, Del.–(BUSINESS WIRE)–QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalysis and clinical trials announces the successful implementation of Oracle…
NEWARK, Del.—(BUSINESS WIRE)—QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalytics and clinical trials, is celebrating its 30-year anniversary in…
NEWARK, Del.—(BUSINESS WIRE)—QPS India, a subsidiary of QPS Holdings, LLC (QPS), a GLP/GCP-compliant global full-service Contract Research Organization, has achieved another significant milestone by…
Webinars
QPS and Bioanalysis Zone: Advancing Bioanalytical Method Development and Validation for Small Molecules in a Changing Regulatory Landscape
Click here to watch the webinar.
QPS and Bioanalysis Zone: Advancing Bioanalytical Method Development and Validation for Small Molecules in a Changing Regulatory Landscape
Click here to watch the webinar.
mRNA Vaccines: Cancer, Autoimmune Disease, and Beyond
June 22, 2026
A single class of drug has the potential to treat infectious diseases, zoonotic diseases, autoimmune diseases, and even cancer. Messenger ribonucleic acid (mRNA) drugs made
New Hope: Vitamin D Could Improve Breast Cancer Outcomes
May 11, 2026
Vitamin D is an essential nutrient, best known for helping the body absorb calcium and maintain strong bones. However, a growing body of evidence shows
Disabling the “Shield” That Enables Pancreatic Cancer
March 11, 2026
Pancreatic cancer is an aggressive, highly lethal malignancy, with some of the highest mortality rates of all major cancers. In fact, per the Pancreatic Cancer
Torching Cancer Using Tumors’ Own Immune Cells
February 9, 2026
Throughout the human body, in virtually every tissue and organ, white blood cells called macrophages are waging a constant battle. These hardworking immune cells destroy
Enzyme of Death Kills Cancer Cells
January 26, 2026
Today’s cancer drugs are more sophisticated and accessible than ever before. But unfortunately, cancer drug resistance remains a life-threatening challenge for patients and cancer care
Unwelcome Trends: Why More Young Adults Are Facing Cancer
October 13, 2025
At age 29, with unrelenting abdominal pain, Ryan Decembrino pushed past reassurances and demanded answers. A colonoscopy detected a tumor, and surgery and chemotherapy followed.
The Role of AI in the Fight Against Cancer
August 13, 2025
Picture your GPS system of choice — Google Maps, Apple Maps, and the like. You plug in a location, follow the directions, and arrive at
Cracking Cancer’s Spread: New Target Identified to Block Bone Metastasis
July 21, 2025
Cancer’s cruelest trick might be its ability to migrate from its initial site and invade other organs and systems, with bones being one of the
Oncology: How Losing the Y Chromosome Affects Outcomes
July 14, 2025
Hair thinning and loss are highly visible and common changes associated with aging in men. At the same time, many men experience cellular changes that
Unanswered Questions: Mysterious Cluster of Brain Tumors Investigated at Massachusetts Hospital
June 2, 2025
Six nurses working on the fifth-floor maternity unit at Newton-Wellesley Hospital in Massachusetts have been diagnosed with benign brain tumors, sparking concern about a cancer
The Food Factor: How Diet Shapes Cancer Risk
March 24, 2025
New research continually adds to our knowledge of the effects of diet on cancer risk. Among recent findings, detailed below, are the protective effects of
AI Mammography May Be the Future of Breast Cancer Screening
February 26, 2025
In mammography, “density” refers to the amount of dense tissue present in the breast, as measured on a standard mammogram. Dense tissue, such as glandular
Diet Changes to Slow Prostate Cancer? Omega-3 Study Has Promising Results
February 17, 2025
Men with early-stage prostate cancer may have a new tool to help slow disease progression. A Phase II trial led by researchers at the UCLA
Gene Therapy Targets Mitochondria to Destroy Cancer Cells
February 10, 2025
Scientists have designed a new gene therapy strategy that uses an optogenetic approach to attack cancer cells from the inside. Optogenetics combines genetic engineering and
Bispecific Antibody Drug Shows Cancer Treatment Potential
October 7, 2024
A new contender in the fight against lung cancer has emerged, with strong clinical trial results for ivonescimab, a bispecific antibody from partners Akeso and
Breaking Ground in Cancer Treatment: First T-Cell Therapy Approved for Solid Tumors
September 16, 2024
Tecelra®, the first engineered T-cell therapy for solid tumors, has received approval from the Food and Drug Administration (FDA) for advanced MAGE-A4+ synovial sarcoma in
Game-Changing Drug for Colon Cancer May Redefine Treatment
August 19, 2024
Clinical trial results show that pembrolizumab, an immunotherapy drug used to treat multiple types of cancer, can dramatically improve outcomes for patients with colorectal cancer
Mapping the Evolution of HIV Treatment and the Path to a Cure
July 24, 2024
In the early days of the human immunodeficiency virus (HIV) epidemic, there was little hope. HIV infection, when untreated, damages the immune system, making people
mRNA Cancer Vaccine Shows Promise Against Glioblastoma
July 8, 2024
In a pioneering first-in-human clinical trial, an mRNA cancer vaccine developed at the University of Florida (UF) has shown promise in treating patients with primary
CAR-T Cell Therapy Shows Promise in Treating Aggressive Brain Tumors
June 13, 2024
Around 200,000 people die from glioblastoma, the most common and most aggressive type of cancerous brain tumor, each year. With a five-year overall survival rate
Executive Summary Biosimilars have advanced from a promising idea to a proven pathway for expanding patient access to biologic therapies and easing pressure on…
Introduction Real-world evidence (RWE) is accelerating drug development by using routinely collected patient health data, known as real-world data (RWD), to deliver insights beyond…
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
NEWARK, Del.–(BUSINESS WIRE)–QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalysis and clinical trials announces the successful implementation of Oracle…
NEWARK, Del.—(BUSINESS WIRE)—QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalytics and clinical trials, is celebrating its 30-year anniversary in…
NEWARK, Del.—(BUSINESS WIRE)—QPS India, a subsidiary of QPS Holdings, LLC (QPS), a GLP/GCP-compliant global full-service Contract Research Organization, has achieved another significant milestone by…